About Remon Medical Technologies
Remon Medical Technologies develops and commercializes smart, miniature implants which enable physicians to assess and treat a variety of medical conditions in a non-invasive manner. Remon's platform has broad applications for patient management, post-operative monitoring, nerve and tissue stimulation, local drug delivery, and drug development.
Remon Medical Technologies Patents
Remon Medical Technologies has filed 23 patents.
Sensors, Congenital heart defects, Implants (medicine), Cardiac anatomy, Cardiology
Sensors, Congenital heart defects, Implants (medicine), Cardiac anatomy, Cardiology
Latest Remon Medical Technologies News
Feb 17, 2021
| AT T Inc., Avisoft Bioacoustics, Honeywell International Inc., Matsushita Electric Industrial, Med-Acoustics, Inc., MSI Transducers Corporation, Pacesetter, Panasonic Corporation, Remon Medical Technologies, Samsung Electronics Co., Ltd. The report analyzes factors affecting bioacoustics sensing market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period. By SMN Bureau The proposed Bioacoustics Sensing Market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics. The Bioacoustics Sensing Market sample report includes an exclusive analysis of COVID-19 pandemic on the market space under scrutiny. The sample represents the format of the overall study which is designed to provide clarity on the structure of the report and some data points demonstrated in an attempt to provide insights into the study quality. >>>Get Sample PDF Copy: Bioacoustics sensing technology is getting popularity in numerous fields, primarily in wearable consumer electronics and healthcare. Bioacoustics sensing technology is capable to potentially convert the user interface with consumer electronics such as mobile phones and others to be projection to augment environments. In the healthcare sector, this technology supports in determining body sounds on skin surface, blood pressure and pulse, observing respiration, and assessment of muscle strength for enhancing stamina, among the other such healthcare applications. The key players profiled in this Bioacoustics Sensing Market study includes: 1. AT T Inc. 10. Samsung Electronics Co., Ltd. The driving factor for bioacoustics sensing market is the sensible growth of artificial intelligence and its significant acceptance. There are several products and solutions of bioacoustics sensing technology in the market, which are based on artificial intelligence such as connected devices and wearable devices. Moreover, the usage of bioacoustics sensing technology within consumer electronic area for creating lighter, and better material, is also expected to support the growth of bioacoustics sensing market aggressively. This research report will give you deep insights about the Bioacoustics Sensing Market and it will also help you in strategic decision making. The final research document is an exhaustive document comprising of 150 pages. All our reports are usually purchased across industries by Executives, Managers, Senior Managers, Strategy people, Directors, Vice Presidents, CXOs, etc. and help them in understanding about the market trends and analysis, competition, industry landscape, market size, market revenue, forecast, COVID-19 impact analysis, SWOT analysis, etc. A thoroughgoing evaluation of the Bioacoustics Sensing market restrains included in the report which represents the difference to drivers of the market and gives scope for strategic insights and developments. The research study has amalgamated the growth analysis of different aspects that enhance the Bioacoustics Sensing market growth scenario. It constitutes key market drivers, restraints and trends that transform the market in either a positive or negative manner. Purchase a Copy of this research report @ The "Global Bioacoustics Sensing Market Analysis to 2027" is a specialized and in-depth study of the bioacoustics sensing industry with a special focus on the global market trend analysis. The report aims to provide an overview of bioacoustics sensing market with detailed market segmentation by component, application, and geography. The global bioacoustics sensing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading bioacoustics sensing market players and offers key trends and opportunities in the market. Additionally, in case you are interested in other topic at the moment, please share your exact requirements with us as apart from our off-the-shelf reports, we also provide customized reports that are prepared keeping in view the clients precise requirements. To let you know, on an annual basis, we publish over 450+ report across 18 distinct industry verticals. ABOUT US: The Insight Partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact US: North America: +1 646 491 9876 Asia-Pacific: +91 20 6727 8686
Remon Medical Technologies Frequently Asked Questions (FAQ)
What is Remon Medical Technologies's latest funding round?
Remon Medical Technologies's latest funding round is Acquired.
How much did Remon Medical Technologies raise?
Remon Medical Technologies raised a total of $10M.
Who are the investors of Remon Medical Technologies?
Investors of Remon Medical Technologies include Boston Scientific, Brooks Keret Group, Triathlon Medical Venture Partners and Medica Partners.
Who are Remon Medical Technologies's competitors?
Competitors of Remon Medical Technologies include Sol-Gel, Savara, MonoSol Rx, Vapore, Iontera and 12 more.
Compare Remon Medical Technologies to Competitors
Next Breath, LLC is a contract pharmaceutical research and development organization dedicated to pre-clinical identification and evaluation of commercially viable respiratory and nasal drug delivery platforms. NB's business will discover and exploit optimal drug and delivery device combinations that will increase the company's partners' probability of success when their products advance into human clinical trials and the marketplace. Next Breath seeks to meet the pharmaceutical industry's outsourcing needs and to provide intellectual expertise to biotechnology companies that are developing inhalation products.
Berkeley Advanced Biomaterials Inc. (BAB) specializes in developing and manufacturing hydroxyapatite (HAP), tricalcium phosphate (TCP), and other calcium-based products. The company's activities are focussed on synthetic bone graft substitutes, sustained-release drug delivery devices, and applications of HAP for protein purification. The company's catalog offers a large variety of products with tailored morphologies and microstructures to match their needs for orthopedic surgery, bone tissue engineering, and life science research. Cem-Ostetic and Bi-Ostetic bone void fillers are approved for sale in the USA and the European Community.
Corium International applies advanced transdermal delivery systems and related technologies to address unmet medical needs. The company has developed two highly differentiated transdermal technologies: MicroCor, a biodegradable microstructure patch technology for active delivery of proteins, peptides and vaccines large molecules that require active transport through the skin; Corplex, an adhesive system and patch technology for delivery of small molecules that may otherwise be difficult to formulate and deliver.
POINT Biomedical is a privately held pharmaceutical company, founded to pursue technologies related to imaging and drug delivery. POINT's core technology is based upon an ultrasonically responsive two-layer, biodegradable microsphere or biSphere. One of the most important features of this technology is the ability to noninvasively trigger the biSpheres to release their contents at sites within the body using externally generated pulses of ultrasound. From this basic platform, POINT is developing a pipeline of products that leverage the unique properties of the biSphere technology in the areas of imaging and therapeutics. POINT has initially focused development of this platform on the assessment of tissue specific blood flow. The lead product, CARDIOsphere, is a pharmaceutical agent that will enable cardiologists to perform myocardial perfusion imaging studies in the office setting using ultrasound rather than more expensive and cumbersome nuclear (or radioisotope) techniques.
Talima Therapeutics is an emerging drug delivery company dedicated to the development of novel products that increase patient choice and improve quality of life. With a unique approach to therapy, we design customized drug-delivery systems that optimize the local therapeutic performance and reduce the undesired systemic side effects enabling us to address unmet needs or underserved markets. We foster a collaborative environment and strive for excellence internally and with our partners. Our lead product is currently in Phase I/II clinical testing for the treatment of onychomycosis, a fungal disease of the nails and we are in the process of planning its pivotal trials.
Vapore is the developer of MyPurMist, a device that provides soothing hot steam on demand. The directed humidification (vapor) of MyPurMist brings warmth into the sinuses which thins mucus and makes breathing easier. The moisture in the mist helps to relieve symptoms by soothing irritated tissues in the nose and throat, calming coughs and reducing dryness.